KR20150004814A - 오스테오폰틴 및 칼슘- 및/또는 스트론튬-함유 입자를 함유하는 나노입자 응집체 - Google Patents
오스테오폰틴 및 칼슘- 및/또는 스트론튬-함유 입자를 함유하는 나노입자 응집체 Download PDFInfo
- Publication number
- KR20150004814A KR20150004814A KR1020147029790A KR20147029790A KR20150004814A KR 20150004814 A KR20150004814 A KR 20150004814A KR 1020147029790 A KR1020147029790 A KR 1020147029790A KR 20147029790 A KR20147029790 A KR 20147029790A KR 20150004814 A KR20150004814 A KR 20150004814A
- Authority
- KR
- South Korea
- Prior art keywords
- species
- opn
- biofilm
- calcium
- strontium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004264 Osteopontin Human genes 0.000 title claims abstract description 203
- 108010081689 Osteopontin Proteins 0.000 title claims abstract description 203
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 168
- 239000002245 particle Substances 0.000 title claims abstract description 91
- 229910052712 strontium Inorganic materials 0.000 title claims abstract description 60
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 239000011575 calcium Substances 0.000 claims abstract description 72
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 67
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 48
- 230000012010 growth Effects 0.000 claims abstract description 38
- 201000010099 disease Diseases 0.000 claims abstract description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 26
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 59
- 239000001506 calcium phosphate Substances 0.000 claims description 58
- 235000011010 calcium phosphates Nutrition 0.000 claims description 58
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 58
- 238000000034 method Methods 0.000 claims description 40
- 241000894007 species Species 0.000 claims description 30
- 241000894006 Bacteria Species 0.000 claims description 28
- 230000000813 microbial effect Effects 0.000 claims description 25
- 241000194017 Streptococcus Species 0.000 claims description 24
- 230000001580 bacterial effect Effects 0.000 claims description 24
- 229910019142 PO4 Inorganic materials 0.000 claims description 15
- 208000002925 dental caries Diseases 0.000 claims description 15
- 239000010452 phosphate Substances 0.000 claims description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 13
- 241000186046 Actinomyces Species 0.000 claims description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 9
- 241000589516 Pseudomonas Species 0.000 claims description 8
- 241000589876 Campylobacter Species 0.000 claims description 7
- 230000035876 healing Effects 0.000 claims description 7
- 208000035143 Bacterial infection Diseases 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 6
- 241000186781 Listeria Species 0.000 claims description 6
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 6
- 208000007565 gingivitis Diseases 0.000 claims description 6
- 206010048038 Wound infection Diseases 0.000 claims description 5
- 241000191940 Staphylococcus Species 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 4
- 201000001245 periodontitis Diseases 0.000 claims description 4
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 3
- 206010064687 Device related infection Diseases 0.000 claims description 3
- 206010014666 Endocarditis bacterial Diseases 0.000 claims description 3
- 206010033078 Otitis media Diseases 0.000 claims description 3
- 241000589886 Treponema Species 0.000 claims description 3
- 208000009361 bacterial endocarditis Diseases 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 201000007119 infective endocarditis Diseases 0.000 claims description 3
- 241001024600 Aggregatibacter Species 0.000 claims description 2
- 241001148536 Bacteroides sp. Species 0.000 claims description 2
- 241000588877 Eikenella Species 0.000 claims description 2
- 241000194036 Lactococcus Species 0.000 claims description 2
- 208000025157 Oral disease Diseases 0.000 claims description 2
- 241000605894 Porphyromonas Species 0.000 claims description 2
- 241000605861 Prevotella Species 0.000 claims description 2
- 238000012937 correction Methods 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 208000030194 mouth disease Diseases 0.000 claims description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 241000606125 Bacteroides Species 0.000 claims 1
- 241000108056 Monas Species 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 96
- 239000007864 aqueous solution Substances 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 23
- 229910052708 sodium Inorganic materials 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 229910052700 potassium Inorganic materials 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 229910052725 zinc Inorganic materials 0.000 description 18
- JOPDZQBPOWAEHC-UHFFFAOYSA-H tristrontium;diphosphate Chemical compound [Sr+2].[Sr+2].[Sr+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JOPDZQBPOWAEHC-UHFFFAOYSA-H 0.000 description 17
- 229910052749 magnesium Inorganic materials 0.000 description 16
- 239000000725 suspension Substances 0.000 description 16
- 229910052792 caesium Inorganic materials 0.000 description 15
- 229910052701 rubidium Inorganic materials 0.000 description 15
- 229910052790 beryllium Inorganic materials 0.000 description 14
- 229910052744 lithium Inorganic materials 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 235000021317 phosphate Nutrition 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 13
- 239000002178 crystalline material Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 238000002441 X-ray diffraction Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 8
- 238000002411 thermogravimetry Methods 0.000 description 8
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 7
- 230000032770 biofilm formation Effects 0.000 description 7
- 239000003792 electrolyte Substances 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000002159 nanocrystal Substances 0.000 description 7
- 210000003296 saliva Anatomy 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008199 coating composition Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000002324 mouth wash Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000002966 varnish Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 239000000551 dentifrice Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 102100040557 Osteopontin Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000193992 Streptococcus downei Species 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000003214 anti-biofilm Effects 0.000 description 3
- 229910052586 apatite Inorganic materials 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 241000186045 Actinomyces naeslundii Species 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 238000003991 Rietveld refinement Methods 0.000 description 2
- 241001134658 Streptococcus mitis Species 0.000 description 2
- 241000194025 Streptococcus oralis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 150000001449 anionic compounds Chemical class 0.000 description 2
- 230000010065 bacterial adhesion Effects 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011176 biofiber Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 238000003235 crystal violet staining Methods 0.000 description 2
- 229940124378 dental agent Drugs 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 210000004262 dental pulp cavity Anatomy 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 229910001412 inorganic anion Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004898 n-terminal fragment Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229940041678 oral spray Drugs 0.000 description 2
- 239000000668 oral spray Substances 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 1
- 102100028042 Alpha-2-HS-glycoprotein Human genes 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000589996 Campylobacter rectus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 229910016523 CuKa Inorganic materials 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 102100022375 Dentin matrix acidic phosphoprotein 1 Human genes 0.000 description 1
- 101710105839 Dentin matrix acidic phosphoprotein 1 Proteins 0.000 description 1
- 241000588878 Eikenella corrodens Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 101001060288 Homo sapiens Alpha-2-HS-glycoprotein Proteins 0.000 description 1
- 101000947120 Homo sapiens Beta-casein Proteins 0.000 description 1
- 101001055531 Homo sapiens Matrix extracellular phosphoglycoprotein Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102100026142 Matrix extracellular phosphoglycoprotein Human genes 0.000 description 1
- 101100365384 Mus musculus Eefsec gene Proteins 0.000 description 1
- 206010065233 Oral bacterial infection Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 241001135221 Prevotella intermedia Species 0.000 description 1
- 241001135225 Prevotella nigrescens Species 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102100030277 Secreted phosphoprotein 24 Human genes 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 101150101561 TOM70 gene Proteins 0.000 description 1
- 241001135235 Tannerella forsythia Species 0.000 description 1
- 241000589892 Treponema denticola Species 0.000 description 1
- 235000012544 Viola sororia Nutrition 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 210000001315 dental pellicle Anatomy 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000002707 nanocrystalline material Substances 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 101150115693 ompA gene Proteins 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 101150090944 otomp gene Proteins 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- TWHXWYVOWJCXSI-UHFFFAOYSA-N phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O TWHXWYVOWJCXSI-UHFFFAOYSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108010053455 riboflavin-binding protein Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 108010079711 secreted phosphoprotein 24 Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0275—Containing agglomerated particulates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12161802 | 2012-03-28 | ||
| EP12161802.9 | 2012-03-28 | ||
| PCT/EP2013/056598 WO2013144247A1 (en) | 2012-03-28 | 2013-03-27 | Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20150004814A true KR20150004814A (ko) | 2015-01-13 |
Family
ID=48141914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147029790A Withdrawn KR20150004814A (ko) | 2012-03-28 | 2013-03-27 | 오스테오폰틴 및 칼슘- 및/또는 스트론튬-함유 입자를 함유하는 나노입자 응집체 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20150044260A1 (https=) |
| EP (1) | EP2830647A1 (https=) |
| JP (1) | JP2015516949A (https=) |
| KR (1) | KR20150004814A (https=) |
| CN (1) | CN104321073A (https=) |
| AR (1) | AR090569A1 (https=) |
| AU (1) | AU2013241750A1 (https=) |
| CA (1) | CA2868684A1 (https=) |
| CL (1) | CL2014002583A1 (https=) |
| EA (1) | EA201491691A1 (https=) |
| MX (1) | MX2014011594A (https=) |
| NZ (1) | NZ700295A (https=) |
| WO (1) | WO2013144247A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5548121B2 (ja) | 2007-05-14 | 2014-07-16 | リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | バイオフィルム中の細菌細胞における生理学的分散応答の誘導 |
| US12109284B2 (en) | 2016-11-08 | 2024-10-08 | Dentherapy Ltd | Compositions comprising fluoride and calcium and method for preparing them |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| US20220183933A1 (en) * | 2019-03-22 | 2022-06-16 | The Board Of Regents Of The University Of Oklahoma | Surface-modified doped titanium dioxide nanoparticles and uses |
| CN111366733B (zh) * | 2020-03-07 | 2022-02-08 | 浙江大学 | 骨桥蛋白作为靶分子在调节肠道菌群定植中的应用 |
| EP4129413A4 (en) * | 2020-03-27 | 2024-04-24 | NOF Corporation | Composition for oral cavity |
| GB202010987D0 (en) | 2020-07-16 | 2020-09-02 | Dentherapy Ltd | Oral care compositions and methods |
| GB202110114D0 (en) | 2021-07-14 | 2021-08-25 | Dentherapy Ltd | Oral care compositions for use in treaatment |
| WO2023187028A1 (en) * | 2022-03-31 | 2023-10-05 | Nadavia Holding Aps | Mouthwash composition comprising one or more strontium salt |
| WO2025008636A1 (en) | 2023-07-06 | 2025-01-09 | Dentherapy Ltd | Oral care compositions for use in the treatment of dental health conditions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7259243B2 (en) * | 2000-01-07 | 2007-08-21 | Arla Foods Amba | Process for isolation of osteopontin from milk |
| NZ507335A (en) | 2000-10-05 | 2004-10-29 | New Zealand Dairy Board | Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP |
| CN1889922B (zh) | 2003-12-01 | 2010-11-24 | 阿尔拉食品公司 | 骨桥蛋白在牙用制剂中的用途 |
| EA200870058A1 (ru) * | 2005-12-16 | 2008-12-30 | Арла Фудс Амба | Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран |
| EP2175841A1 (en) * | 2007-07-16 | 2010-04-21 | Aarhus Universitet | Osteopontin nanoparticles system for drug delivery |
| AU2012222312B2 (en) | 2011-03-03 | 2017-06-08 | Arla Foods Amba | Method for isolating osteopontin using feeds containing cmp or casein species |
-
2013
- 2013-03-27 MX MX2014011594A patent/MX2014011594A/es unknown
- 2013-03-27 CA CA2868684A patent/CA2868684A1/en not_active Abandoned
- 2013-03-27 US US14/387,946 patent/US20150044260A1/en not_active Abandoned
- 2013-03-27 JP JP2015502339A patent/JP2015516949A/ja active Pending
- 2013-03-27 EP EP13717196.3A patent/EP2830647A1/en not_active Withdrawn
- 2013-03-27 NZ NZ700295A patent/NZ700295A/en not_active IP Right Cessation
- 2013-03-27 AU AU2013241750A patent/AU2013241750A1/en not_active Abandoned
- 2013-03-27 KR KR1020147029790A patent/KR20150004814A/ko not_active Withdrawn
- 2013-03-27 WO PCT/EP2013/056598 patent/WO2013144247A1/en not_active Ceased
- 2013-03-27 EA EA201491691A patent/EA201491691A1/ru unknown
- 2013-03-27 CN CN201380025647.3A patent/CN104321073A/zh active Pending
- 2013-04-03 AR ARP130101064A patent/AR090569A1/es unknown
-
2014
- 2014-09-26 CL CL2014002583A patent/CL2014002583A1/es unknown
-
2016
- 2016-04-05 US US15/091,499 patent/US20170065673A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014011594A (es) | 2015-07-06 |
| US20170065673A1 (en) | 2017-03-09 |
| EA201491691A1 (ru) | 2015-04-30 |
| WO2013144247A1 (en) | 2013-10-03 |
| JP2015516949A (ja) | 2015-06-18 |
| CN104321073A (zh) | 2015-01-28 |
| CA2868684A1 (en) | 2013-10-03 |
| AU2013241750A8 (en) | 2014-10-23 |
| US20150044260A1 (en) | 2015-02-12 |
| AU2013241750A1 (en) | 2014-10-09 |
| EP2830647A1 (en) | 2015-02-04 |
| NZ700295A (en) | 2016-07-29 |
| AR090569A1 (es) | 2014-11-19 |
| CL2014002583A1 (es) | 2015-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20150004814A (ko) | 오스테오폰틴 및 칼슘- 및/또는 스트론튬-함유 입자를 함유하는 나노입자 응집체 | |
| He et al. | Polyzwitterion manipulates remineralization and antibiofilm functions against dental demineralization | |
| JP7058344B2 (ja) | 歯肉健康を促進するための口腔ケア組成物 | |
| JP7058343B2 (ja) | 歯肉健康を促進するための口腔ケア組成物 | |
| Chitra et al. | Impact of copper on in-vitro biomineralization, drug release efficacy and antimicrobial properties of bioactive glasses | |
| JP7058342B2 (ja) | 歯肉健康を促進するための口腔ケア組成物 | |
| AU2018415249B2 (en) | Oral care compositions for promoting gum health | |
| JP5553396B2 (ja) | 再石灰化促進剤及び口腔用組成物 | |
| Kovtun et al. | Chlorhexidine-loaded calcium phosphate nanoparticles for dental maintenance treatment: combination of mineralising and antibacterial effects | |
| RU2716134C2 (ru) | Стабилизированные композиции на основе олова (II) | |
| Abdelnabi et al. | Effect of different formulations and application methods of coral calcium on its remineralization ability on carious enamel | |
| JP2008521754A (ja) | 安定化したリン酸カルシウム複合体 | |
| WO2013068020A1 (en) | Dental care products containing biomimetic hydroxyapatite particles having a lactoferrin-functionalized surface | |
| Babayevska et al. | Novel nanosystems to enhance biological activity of hydroxyapatite against dental caries | |
| RU2722306C1 (ru) | Композиция для регуляции микроэлементного обмена в полости рта | |
| Mu et al. | Yellow light and ultrasound Dual-responsive strontium-doped zinc oxide composites for dental caries prevention and remineralization | |
| Xu et al. | VMT/ACP/Dextran composite nanosheets against dental caries through promoting mineralization of dentin tubules, pH buffering, and antibacterial | |
| Wang et al. | Near-infrared light-triggered smart response platform integrating CeO2@ Black phosphorus for enhanced antimicrobial, anti-inflammatory, and osseointegration properties of titanium implants | |
| Cao et al. | Antibacterial silver-doped calcium phosphate synthesized by an enzymatic strategy for initial caries treatment | |
| Tabari et al. | The Effect of Silicone Oil and Nano-hydroxyapatite/Chitosan Powder on Microhardness and Surface Structure of Primary Teeth Enamel After Iron Drop Consumption. | |
| WO2005000251A1 (ja) | 再石灰化促進剤、口腔用組成物 | |
| Sulistyawati et al. | Effectiveness of Nano-hydroxyapatite in Caries Prevention: Literature Review | |
| Fahmy | The Effect of Amorphous Calcium Phosphate Nanoparticles Loaded in Chlorhexidine as an Intra-canal Medicament on Radicular Dentin Microhardness (An In-Vitro Study) | |
| Battistella et al. | Dental tissue engineering: a new approach to dental tissue reconstruction | |
| Lv et al. | Remineralized evaluation of nano-hydroxyapatite to artificial caries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20141023 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |